BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28566201)

  • 1. Racial Variation in the Outcome of Subsequent Prostate Biopsies in Men With an Initial Diagnosis of Atypical Small Acinar Proliferation.
    Scott Libby R; Kramer JJ; Tue Nguyen HM; Feibus A; Thomas R; Silberstein JL
    Clin Genitourin Cancer; 2017 Dec; 15(6):e995-e999. PubMed ID: 28566201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.
    Leone A; Gershman B; Rotker K; Butler C; Fantasia J; Miller A; Afiadata A; Amin A; Zhou A; Jiang Z; Sebo T; Mega A; Schiff S; Pareek G; Golijanin D; Yates J; Karnes RJ; Renzulli J
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):68-71. PubMed ID: 26857145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.
    Sterling WA; Weiner J; Schreiber D; Mehta K; Weiss JP
    Int Urol Nephrol; 2016 Dec; 48(12):2015-2021. PubMed ID: 27580731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
    Carver BS; Bozeman CB; Simoneaux WJ; Venable DD; Kattan MW; Eastham JA
    J Urol; 2004 Nov; 172(5 Pt 1):1853-5. PubMed ID: 15540737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the serum testosterone levels as a predictor of prostate cancer in patients with atypical small acinar proliferation at the first prostate biopsy.
    Dell'Atti L; Galosi AB
    Asian J Androl; 2018; 20(1):15-18. PubMed ID: 28695864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial variation in prostate needle biopsy templates directed anterior to the peripheral zone.
    Feibus AH; Levy J; McCaslin IR; Doucet ME; Sholl AB; Moparty K; Thomas R; Sartor O; Silberstein JL
    Urol Oncol; 2016 Aug; 34(8):336.e1-6. PubMed ID: 27155916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
    Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
    Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men.
    Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Albala DM; Donatucci CF; Moul JW
    Urology; 2010 Nov; 76(5):1058-62. PubMed ID: 20035982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Yanke BV; Carver BS; Bianco FJ; Simoneaux WJ; Venable DD; Powell IJ; Eastham JA
    BJU Int; 2006 Oct; 98(4):783-7. PubMed ID: 16978273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer detection following diagnosis of atypical small acinar proliferation.
    Ericson KJ; Wenger HC; Rosen AM; Kiriluk KJ; Gerber GS; Paner GP; Eggener SE
    Can J Urol; 2017 Apr; 24(2):8714-8720. PubMed ID: 28436357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening.
    Gu J; Chery L; González GMN; Huff C; Strom S; Jones JA; Griffith DP; Canfield SE; Wang X; Huang X; Roberson P; Meng QH; Troncoso P; Ittmann M; Covinsky M; Scheurer M; Irizarry Ramirez M; Pettaway CA
    Prostate; 2024 May; 84(7):694-705. PubMed ID: 38477020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men.
    Waterhouse RL; Van Neste L; Moses KA; Barnswell C; Silberstein JL; Jalkut M; Tutrone R; Sylora J; Anglade R; Murdock M; Shiffman Z; Vandenberg T; Shah N; Carter M; Krispin M; Groskopf J; Van Criekinge W
    Urology; 2019 Jun; 128():62-65. PubMed ID: 29660369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies.
    Scattoni V; Roscigno M; Freschi M; Dehò F; Raber M; Briganti A; Fantini G; Nava L; Montorsi F; Rigatti P
    Arch Ital Urol Androl; 2005 Mar; 77(1):31-6. PubMed ID: 15906787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation.
    Totaro A; Di Gianfrancesco L; Pinto F; Racioppi M; Palermo G; Campetella M; Santoro AA; Arbia G; Sacco E
    Urologia; 2021 Aug; 88(3):194-199. PubMed ID: 33579180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
    Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
    Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.